Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
about
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerTestosterone therapy and prostate cancer.Potential overtreatment among men aged 80 years and older with localized prostate cancer in Japan.Physicians' Perceptions of Factors Influencing the Treatment Decision-making Process for Men With Low-risk Prostate Cancer.Influence of Men's Personality and Social Support on Treatment Decision-Making for Localized Prostate Cancer.Decision-making processes among men with low-risk prostate cancer: A survey study.Physicians' perspectives on the informational needs of low-risk prostate cancer patients.Patient and provider experiences with active surveillance: A scoping review.Discussing Conservative Management With Older Patients With CKD: An Interview Study of Nephrologists.Prostate Cancer Patient Characteristics Associated With a Strong Preference to Preserve Sexual Function and Receipt of Active Surveillance.Quality of life in active surveillance and the associations with decision-making-a literature review.
P2860
Q26738703-B6401B98-4303-4718-AB6F-FFED647EA5DAQ37531045-CC50256D-4C42-4675-AAB7-68F8678DA96DQ38736557-EF9EC770-A1AF-41F6-A5CB-EEA50CE2A0D5Q38813806-948C2081-E94F-4BB3-83CD-7E040688DDF9Q41141658-39BFE339-3011-4002-A833-9299A70B11B9Q46259067-F3E6BDDB-2381-493A-A6A3-E7465B2FB7C1Q46916722-8C08A98B-D4A6-4976-B519-4008B85565F2Q48105242-B4B8712A-B5F2-4F3C-9A4B-7AA9BB8E2A42Q49360136-053A9A2D-AADD-4953-BF0F-38FF5096EA31Q50089850-E021C77D-FB2E-4DE5-B155-FBD07F832A01Q55003987-4EC1F39C-5B2B-46E0-9B7A-3161E7F0C7FE
P2860
Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Treatment Preferences for Acti ...... with Low-Risk Prostate Cancer.
@en
Treatment Preferences for Acti ...... with Low-Risk Prostate Cancer.
@nl
type
label
Treatment Preferences for Acti ...... with Low-Risk Prostate Cancer.
@en
Treatment Preferences for Acti ...... with Low-Risk Prostate Cancer.
@nl
prefLabel
Treatment Preferences for Acti ...... with Low-Risk Prostate Cancer.
@en
Treatment Preferences for Acti ...... with Low-Risk Prostate Cancer.
@nl
P2093
P2860
P50
P1476
Treatment Preferences for Acti ...... with Low-Risk Prostate Cancer.
@en
P2093
Amethyst Leimpeter
Amy J Starosta
Catherine A Tomko
Charlotte J Hagerman
David Aaronson
Kathryn L Taylor
Kimberly M Davis
Stephen K Van Den Eeden
Tania Lobo
P2860
P304
P356
10.1158/1055-9965.EPI-15-1079
P577
2016-06-02T00:00:00Z